The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
08
2022
accepted:
24
03
2023
medline:
17
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
The SARS-CoV-2 Alpha variant was associated with increased transmission relative to other variants present at the time of its emergence and several studies have shown an association between Alpha variant infection and increased hospitalisation and 28-day mortality. However, none have addressed the impact on maximum severity of illness in the general population classified by the level of respiratory support required, or death. We aimed to do this. In this retrospective multi-centre clinical cohort sub-study of the COG-UK consortium, 1475 samples from Scottish hospitalised and community cases collected between 1st November 2020 and 30th January 2021 were sequenced. We matched sequence data to clinical outcomes as the Alpha variant became dominant in Scotland and modelled the association between Alpha variant infection and severe disease using a 4-point scale of maximum severity by 28 days: 1. no respiratory support, 2. supplemental oxygen, 3. ventilation and 4. death. Our cumulative generalised linear mixed model analyses found evidence (cumulative odds ratio: 1.40, 95% CI: 1.02, 1.93) of a positive association between increased clinical severity and lineage (Alpha variant versus pre-Alpha variants). The Alpha variant was associated with more severe clinical disease in the Scottish population than co-circulating lineages.
Identifiants
pubmed: 37053201
doi: 10.1371/journal.pone.0284187
pii: PONE-D-22-22604
pmc: PMC10101505
doi:
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0284187Subventions
Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/11
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V038613/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC UU 00002/11
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00034/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC UU 1201412
Pays : United Kingdom
Informations de copyright
Copyright: © 2023 Pascall et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet Microbe. 2020 Jul;1(3):e99-e100
pubmed: 32835336
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136
pubmed: 34423834
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739254
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Nat Microbiol. 2021 Jan;6(1):112-122
pubmed: 33349681
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
BMJ Open Respir Res. 2021 Sep;8(1):
pubmed: 34544733
Nature. 2022 Feb;602(7897):487-495
pubmed: 34942634
BMJ Open. 2022 Feb 8;12(2):e055474
pubmed: 35135773
Euro Surveill. 2022 May;27(20):
pubmed: 35593163
Med Drug Discov. 2021 Jun;10:100086
pubmed: 33681755
Clin Infect Dis. 2022 Aug 24;75(1):e1120-e1127
pubmed: 34487522
Cell Host Microbe. 2021 Apr 14;29(4):529-539.e3
pubmed: 33705729
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
BMJ. 2021 Jun 15;373:n1412
pubmed: 34130987
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Cell Rep. 2021 Mar 23;34(12):108890
pubmed: 33713594
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406